Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Introducing automated controls will shift focus from managing the test setup to analyzing the data and expediting time to market for the Company’s first commercial pilot plant SANTA CLARITA, CA, July...
-
TETmedical, Inc. a clinical stage medical diagnostic company received FDA breakthrough technology designation for its NSE-Functional Activity Stroke Test
-
Successful technical validation and strategic NuCube Energy collaboration mark transition to engineering phase SANTA CLARITA, CA, May 05, 2026 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCQB: NEWH),...
-
LAS VEGAS, Dec. 02, 2025 (GLOBE NEWSWIRE) -- In a digital world where trust is eroding and systemic vulnerabilities threaten global ecosystems, Astradyne Inc. (Astral Dynamic Networks) is...
-
TORONTO and HAIFA, Israel, Nov. 12, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that, further to its...
-
Coupling ThermoLoop with Small Modular Reactors (SMRs) to Produce the World’s Cheapest Clean Hydrogen SANTA CLARITA, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCQB: NEWH), the...
-
The Company will reveal a massive source of heat for its novel ThermoLoop™ heat-based water-splitting system SANTA CLARITA, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCQB:NEWH),...
-
Dr. Morales brings expertise in dynamic reactor operation and advanced catalytic processes Santa Clarita, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCQB:NEWH), the developer of...
-
TORONTO and HAIFA, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) today announced that an independent study...
-
TORONTO and HAIFA, Israel, July 25, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that the Falling Walls...